← Eichor
Condition: Soft Tissue Infections Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Soft Tissue Infections

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumo
Phase 1/Phase 2 · 71 location(s) · Merck Sharp & Dohme LLC · NCT06395103Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial
Phase 4 · 1 location(s) · Frieder Schaumburg · NCT05899140Melodi Matrix™ in Breast Reconstruction
NA · 10 location(s) · Melodi Health, Inc. · NCT06027996Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07066982FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).
Phase N/A · 4 location(s) · University of Cagliari · NCT07359651Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
NA · 14 location(s) · University of Utah · NCT05471908Fosfomycin I.v. for Treatment of Severely Infected Patients
Phase N/A · 50 location(s) · Infectopharm Arzneimittel GmbH · NCT02979951Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT03889899Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Phase N/A · 8 location(s) · AIDS Malignancy Consortium · NCT05663502Adjunctive Hyperbaric Oxygen Treatment for Patients With Necrotizing Soft-Tissue Infection (HOT-NSTI Trial).
Phase 4 · 1 location(s) · Ole Hyldegaard · NCT07489274Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cance
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00006518A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05859074Trial of Ixazomib for Kaposi Sarcoma
Phase 2 · 11 location(s) · AIDS Malignancy Consortium · NCT04305691Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT03300830The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
NA · 1 location(s) · Washington University School of Medicine · NCT03482245Natural History Study of Kaposi Sarcoma
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT06375122The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®
NA · 1 location(s) · Benjamin T. Miller · NCT06857708Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Phase N/A · 1 location(s) · University of California, Irvine · NCT06002607Infrared Thermography for Diagnosis of Musculoskeletal Infections
Phase N/A · 1 location(s) · Sheffield Children's NHS Foundation Trust · NCT07388017Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic
Phase N/A · 8 location(s) · Eric R. Henderson · NCT06877793Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT06751355Myriad™ Augmented Soft Tissue Reconstruction Registry
Phase N/A · 15 location(s) · Aroa Biosurgery Limited · NCT05243966Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT04534127Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04303117Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and I
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT07308886Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04941274Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931The Effect of Local Application of Tranexamic Acid Versus Placebo on Postoperative Complications in Plastic Surgery
Phase 4 · 1 location(s) · St. Olavs Hospital · NCT06270407Irrigating vs Traditional Negative Pressure Wound Therapy to Treat Necrotizing Soft Tissue Infections
NA · 1 location(s) · HealthPartners Institute · NCT07120386
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.